Sumaiya Krishnamoorthi, Langford Dianne, Natarajaseenivasan Kalimuthusamy, Shanmughapriya Santhanam
Medical Microbiology Laboratory, Department of Microbiology, Centre for Excellence in Life Sciences, Bharathidasan University, Tiruchirappalli 620 024, Tamil Nadu, India.
Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Pharmacol Ther. 2022 May;233:108024. doi: 10.1016/j.pharmthera.2021.108024. Epub 2021 Oct 19.
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine encoded within a functionally polymorphic genetic locus. MIF was initially recognized as a cytokine generated by activated T cells, but in recent days it has been identified as a multipotent key cytokine secreted by many other cell types involved in immune response and physiological processes. MIF is a highly conserved 12.5 kDa secretory protein that is involved in numerous biological processes. The expression and secretion profile of MIF suggests that MIF to be ubiquitously and constitutively expressed in almost all mammalian cells and is vital for numerous physiological processes. MIF is a critical upstream mediator of host innate and adaptive immunity and survival pathways resulting in the clearance of pathogens thus playing a protective role during infectious diseases. On the other hand, MIF being an immune modulator accelerates detrimental inflammation, promotes cancer metastasis and progression, thus worsening disease conditions. Several reports demonstrated that genetic and physiological factors, including MIF gene polymorphisms, posttranslational regulations, and receptor binding control the functional activities of MIF. Taking into consideration the multi-faceted role of MIF both in physiology and pathology, we thought it is timely to review and summarize the expressional and functional regulation of MIF, its functional mechanisms associated with its beneficial and pathological roles, and MIF-targeting therapies. Thus, our review will provide an overview on how MIF is regulated, its response, and the potency of the therapies that target MIF.
巨噬细胞移动抑制因子(MIF)是一种由功能多态性基因座编码的促炎细胞因子。MIF最初被认为是由活化T细胞产生的细胞因子,但近年来已被确定为参与免疫反应和生理过程的许多其他细胞类型分泌的多能关键细胞因子。MIF是一种高度保守的12.5 kDa分泌蛋白,参与众多生物学过程。MIF的表达和分泌模式表明,MIF在几乎所有哺乳动物细胞中普遍且组成性表达,对众多生理过程至关重要。MIF是宿主固有免疫和适应性免疫以及生存途径的关键上游介质,可导致病原体清除,因此在传染病期间发挥保护作用。另一方面,MIF作为一种免疫调节剂会加速有害炎症,促进癌症转移和进展,从而使疾病状况恶化。多项报告表明,包括MIF基因多态性、翻译后调控和受体结合在内的遗传和生理因素控制着MIF的功能活性。考虑到MIF在生理和病理方面的多方面作用,我们认为及时回顾和总结MIF的表达和功能调控、其与有益和病理作用相关的功能机制以及靶向MIF的治疗方法是很有必要的。因此,我们的综述将概述MIF是如何被调控的、其反应以及靶向MIF的治疗方法的效力。